||**Royal London Hospital Kidney Patienst Association**<br>**2**|**Royal London Hospital Kidney Patienst Association**<br>**2**|**Royal London Hospital Kidney Patienst Association**<br>**2**|**66660**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|9/1/2025|**To**|8/31/2026||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**10,793**<br>**72,668**<br>**400**<br>**6,717**<br>**1,000**<br>**1,629**<br>**-**<br>**-**<br>**93,208**<br>**-**<br>**-**<br>**-**<br>**93,208**<br>**3,305**<br>**6,464**<br>**762**<br>**-**<br>**8,634**<br>**542**<br>**234**<br>**190**<br>**-**<br>**20,131**<br>**-**<br>**-**<br>**-**<br>**20,131**<br>**73,077**<br>**-**<br>**-**<br>**73,077**|**Last year**<br>**to the nearest £**|
|Donations<br>Bequest<br>Poole<br>Transplant Games – Members'<br>Contributions<br>Global Kidney Foundation – Tx Games<br>Sponsorship|**10,793**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**10,793**|**-**|
||**72,668**|||**72,668**|**-**|
||**400**|||**400**|**-**|
||**6,717**|||**6,717**|**-**|
|||||**1,000**|**-**|
|Bank Interest|**1,629**|||**1,629**|**-**|
||**-**|||**-**|**-**|
||**-**|||**-**|**-**|
|**_Sub total_**_(Gross income for AR)_|**92,208**<br>|||**93,208**|**-**|
|||||||
||||**-**<br>**-**<br>**-**|**-**||
|||||**-**|**-**|
|||||**-**|**-**|
|||||||
||||**-**|**93,208**|**-**|
|||||||
||||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**3,305**|**-**|
|||||**6,464**|**-**|
|||||**762**|**-**|
|||||**-**|**-**|
|||||**8,634**|**-**|
|||||**542**|**-**|
|||||**234**|**-**|
|||||**190**|**-**|
|||||**-**|**-**|
|||||**20,131**|**-**|
|||||||
||||**-**<br>**-**<br>**-**|**-**||
|||||**-**||
|||||**-**|**-**|
|||||||
||||**-**|**20,131**|**-**|
|||||||
|||**-**|**-**<br>**-**<br>**-**<br>**-**|**73,077**|**-**|
|||**-**||**-**|**-**|
|||**-**||**-**|**-**|
|||**-**||**73,077**|**-**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>Barclays Business Current Account<br>Barclays Business Premium Account<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Flat 4, Seaton Court 65 Surrey Road**<br>**Branksome Poole BH12 1HG**|**to nearest £**<br>**to nearest £**<br>**4,801**<br>**-**<br>**199,513**<br>**-**<br>**-**<br>**-**<br>**204,315**<br>**-**<br>Agreement Error<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**147,278**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Mark O'Callaghan<br>Marie Given<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||Mark O'Callaghan|11/4/2026|
|||Marie Given|**11/4/2026**|



